Michael J. Hallek
University of Cologne
Affiliation University of Cologne Top Publications Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines (2008) – 3,810 citations Comprehensive genomic profiles of small cell lung cancer (2015) – 2,453 citations Addition of rituximab to fludarabine ... <a title="Michael J. Hallek" class="read-more" href="https://journalsworld.com/researchers/michael-j-hallek/" aria-label="Read more about Michael J. Hallek">Read more</a>
Read biography ↓Biography, research & contributions
Affiliation
University of Cologne
Top Publications
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines (2008) - 3,810 citations
- Comprehensive genomic profiles of small cell lung cancer (2015) - 2,453 citations
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial (2010) - 1,892 citations
- iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL (2018) - 1,767 citations
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia (2014) - 1,713 citations
At a glance
- Full name
- Michael J. Hallek
- ORCID
- 0000-0002-7425-4455
- OpenAlex ID
- https://openalex.org/A5076077834
Research interests
- Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- 3,810OpenAlex citations
- 2,453OpenAlex citations
- 1,892OpenAlex citations
- 1,767OpenAlex citations
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia ↗2014 · New England Journal of Medicine1,713OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia ↗2014 · New England Journal of Medicine
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 21:30:56
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.